Geode Capital Management
INKT icon

Geode Capital Management’s MiNK Therapeutics INKT Stock Holding History

Geode Capital Management’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Sell
15,573
-1,772
-10% -$20.6K ﹤0.01% 3947
2026
Q1 		$183K Buy
17,345
+3,098
+22% +$34.5K ﹤0.01% 3939
2025
Q4 		$159K Buy
14,247
+1,441
+11% +$18.6K ﹤0.01% 3985
2025
Q3 		$179K Buy
12,806
+1,314
+11% +$21K ﹤0.01% 3962
2025
Q2 		$86K Buy
11,492
+238
+2% +$1.79K ﹤0.01% 4102
2025
Q1 		$97.3K Buy
11,254
+1,643
+17% +$14.6K ﹤0.01% 4039
2024
Q4 		$67K Sell
9,611
-187
-2% -$1.27K ﹤0.01% 4190
2024
Q3 		$73.5K Buy
9,798
+163
+2% +$1.38K ﹤0.01% 4178
2024
Q2 		$91.5K Buy
9,635
+749
+8% +$7.29K ﹤0.01% 4161
2024
Q1 		$80.7K Sell
8,886
-130
-1% -$1.21K ﹤0.01% 4226
2023
Q4 		$96.9K Hold
9,016
– – ﹤0.01% 4196
2023
Q3 		$106K Sell
9,016
-256
-3% -$4.17K ﹤0.01% 4231
2023
Q2 		$195K Buy
9,272
+6,742
+266% +$135K ﹤0.01% 4057
2023
Q1 		$48.6K Hold
2,530
– – ﹤0.01% 4527
2022
Q4 		$65K Buy
2,530
+212
+9% +$4.98K ﹤0.01% 4520
2022
Q3 		$48K Hold
2,318
– – ﹤0.01% 4775
2022
Q2 		$32K Sell
2,318
-1,072
-32% -$20.2K ﹤0.01% 4860
2022
Q1 		$76K Buy
3,390
+1,032
+44% +$31K ﹤0.01% 4728
2021
Q4 		$105K Buy
+2,358
New +$280K ﹤0.01% 4717

Other funds holding INKT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
PP
Paladin Partners Hartland, Wisconsin $151M AUM

Geode Capital Management's INKT Position: Q2 2026 in Review

Geode Capital Management reduced its MiNK Therapeutics (INKT) stake by 10% in Q2 2026, selling an estimated $20.6K and leaving 15,573 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3947.

Geode Capital Management first reported a position in INKT in Q4 2021 and has held it in 19 quarters since. The position peaked at $195K in Q2 2023. 27 funds tracked by Wall St. Rank hold INKT as of Q2 2026.

  • Geode Capital Management held 15,573 shares of MiNK Therapeutics worth $182K as of Q2 2026.
  • Geode Capital Management sold 1,772 MiNK Therapeutics shares in Q2 2026, an estimated $20.6K.
  • MiNK Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3947 holding.
  • Geode Capital Management first reported a position in MiNK Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Geode Capital Management's MiNK Therapeutics position peaked at $195K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.